• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chron Respir Dis . Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A syst

tetano

Editor, Senior Moderator
Chron Respir Dis


. Jan-Dec 2021;18:14799731211002240.
doi: 10.1177/14799731211002240.
Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis


Kevin Cares-Marambio[SUP] 1 [/SUP], Yessenia Montenegro-Jim?nez[SUP] 1 [/SUP], Rodrigo Torres-Castro[SUP] 1 2 [/SUP], Roberto Vera-Uribe[SUP] 1 2 [/SUP], Yolanda Torralba[SUP] 3 4 [/SUP], Xavier Alsina-Restoy[SUP] 3 [/SUP], Luis Vasconcello-Castillo[SUP] 1 2 [/SUP], Jordi Vilar?[SUP] 2 5 [/SUP]



Affiliations

Abstract

Knowledge on the sequelae of Coronavirus Disease 2019 (COVID-19) remains limited due to the relatively recent onset of this pathology. However, the literature on other types of coronavirus infections prior to COVID-19 reports that patients may experience persistent symptoms after discharge. To determine the prevalence of respiratory symptoms in survivors of hospital admission after COVID-19 infection. A living systematic review of five databases was performed in order to identify studies which reported the persistence of respiratory symptoms in COVID-19 patients after discharge. Two independent researchers reviewed and analysed the available literature, and then extracted and assessed the quality of those articles. Of the 1,154 reports returned by the initial search nine articles were found, in which 1,816 patients were included in the data synthesis. In the pooled analysis, we found a prevalence of 0.52 (CI 0.38-0.66, p < 0.01, I [SUP]2[/SUP] = 97%), 0.37 (CI 0.28-0.48, p < 0.01, I [SUP]2[/SUP] = 93%), 0.16 (CI 0.10-0.23, p < 0.01, I [SUP]2[/SUP] = 90%) and 0.14 (CI 0.06-0.24, p < 0.01, I [SUP]2[/SUP] = 96%) for fatigue, dyspnoea, chest pain, and cough, respectively. Fatigue, dyspnoea, chest pain, and cough were the most prevalent respiratory symptoms found in 52%, 37%, 16% and 14% of patients between 3 weeks and 3 months, after discharge in survivors of hospital admission by COVID-19, respectively.

Keywords: COVID-19; chest pain; cough; dyspnoea; fatigue; respiratory symptoms.
 
Back
Top Bottom